Home > Financial Ratios > ANUH PHARMA

ANUH PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results

ANUH PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 9.9810.3813.946.777.94

What is the latest EV/Core EBITDA ratio of ANUH PHARMA ?

The latest EV/Core EBITDA ratio of ANUH PHARMA is 9.98 based on Mar2026 Standalone results.
Year EV/Core EBITDA
Mar20269.98
Mar202510.38
Mar202413.94
Mar20236.77
Mar20227.94

How is EV/Core EBITDA of ANUH PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 9.98
-3.85
Mar2025 10.38
-25.54
Mar2024 13.94
105.91
Mar2023 6.77
-14.74
Mar2022 7.94 -

Other Financial Ratios of ANUH PHARMA


Compare EV/Core EBITDA ratio of peers of ANUH PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANUH PHARMA ₹792.5 Cr -5.3% -15.4% 1.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,831.0 Cr -0.4% -6.1% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,074.0 Cr 0.9% -3.3% 39.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,355.0 Cr 0.1% -7.2% 28.2% Stock Analytics
CIPLA ₹107,439.0 Cr -0.3% -4% -15.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,417.0 Cr 1.5% 3.1% 0.4% Stock Analytics


ANUH PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANUH PHARMA

-5.3%

-15.4%

1.3%

SENSEX

0.6%

-1.4%

-10.7%


You may also like the below Video Courses